These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 21992013)
1. A case of primary retroperitoneal serous adenocarcinoma. Arichi N; Yasumoto H; Mitsui Y; Hiraoka T; Honda S; Shiina H; Igawa M Int J Urol; 2011 Dec; 18(12):844-6. PubMed ID: 21992013 [TBL] [Abstract][Full Text] [Related]
2. Resection for Primary Retroperitoneal Serous Adenocarcinoma and Liver Metastasis. Nakatake R; Ishizaki M; Ishida M; Matsui K; Kawaguchi Y; Kaibori M Intern Med; 2018 Dec; 57(23):3371-3375. PubMed ID: 30101904 [TBL] [Abstract][Full Text] [Related]
3. A rare case of primary retroperitoneal mucinous adenocarcinoma: a case report. Cupp JS; Illeck J; Rahbar N; Rettenmaier MA; Goldstein BH J Reprod Med; 2013; 58(1-2):85-8. PubMed ID: 23447927 [TBL] [Abstract][Full Text] [Related]
4. A primary retroperitoneal serous cystadenocarcinoma with clinically aggressive behavior. Kaku M; Ohara N; Seima Y; Imanishi K; Tomura N; Kobayashi A; Yamasaki M; Hirata Y; Murao S Arch Gynecol Obstet; 2004 Dec; 270(4):302-6. PubMed ID: 14551796 [TBL] [Abstract][Full Text] [Related]
5. Primary retroperitoneal serous adenocarcinoma: A case report of rare malignancy with literature review. Win TT; Aye SN; Abdul Hamad NS; Tuan Sharif SE Indian J Cancer; 2021; 58(2):262-266. PubMed ID: 33402586 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC). Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185 [TBL] [Abstract][Full Text] [Related]
11. Enormous cystic tumor of peritoneal psammocarcinoma exhibiting complete response to Cisplatin and cyclophosphamide after suboptimal cytoreduction: case report and review of the literature. Takahashi R; Ueda Y; Shioji M; Adachi S; Ohashi H; Morii E; Aozasa K; Yoshino K; Fujita M; Enomoto T; Kimura T; Tokuhira A Gynecol Obstet Invest; 2012; 74(2):165-70. PubMed ID: 22584287 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma. Low JS; Wong EH; Tan HS; Yap SP; Chua EJ; Sethi VK; Soh LT; Low J; Tay EH; Chew SH Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454 [TBL] [Abstract][Full Text] [Related]
13. The role of optimal debulking in advanced stage serous carcinoma of the uterus. Moller KA; Gehrig PA; Van Le L; Secord AA; Schorge J Gynecol Oncol; 2004 Jul; 94(1):170-4. PubMed ID: 15262137 [TBL] [Abstract][Full Text] [Related]
14. Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management. Grønlund B Dan Med Bull; 2006 Aug; 53(3):232-57. PubMed ID: 17092448 [No Abstract] [Full Text] [Related]
15. Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review. Chae YK; Saleem N; Roh Y; Bilal H; Viveiros P; Sukhadia B; Lin X; Sheikh MM; Park LC BMC Cancer; 2019 Jul; 19(1):748. PubMed ID: 31362708 [TBL] [Abstract][Full Text] [Related]
16. Peritoneal implantations of papillary serous ovarian cystadenocarcinoma 13 days after initial laparoscopic treatment for a presumed benign ovarian cyst. Papoutsis D; Rodolakis A; Haidopoulos D; Sotiropoulou M; Antsaklis A Eur J Gynaecol Oncol; 2009; 30(1):103-5. PubMed ID: 19317271 [TBL] [Abstract][Full Text] [Related]
17. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging? Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226 [TBL] [Abstract][Full Text] [Related]
18. [A case of ovarian cancer stage IV and advanced rectal cancer responding to paclitaxel/carboplatin]. Kawaguchi R; Furukawa N; Morimoto Y; Ohi M; Osawa T; Koike H; Miyake T Gan To Kagaku Ryoho; 2004 Apr; 31(4):619-22. PubMed ID: 15114712 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation]. Gao KF; Liu FY; Chen FJ; Feng YL Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668 [TBL] [Abstract][Full Text] [Related]